Exelixis | Obroty



Sales Zmiana Data
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 13.59B 1.3B 2025-03
Bayer EUR 11.73B 1.76B 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Cytokinetics USD 16.93M 16.46M 2024-12
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 566.76M 27.21M 2024-12
Genmab DKK 64.41B 58.87B 2024-12
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Sanofi EUR 11.26B 3.5B 2024-12
Takeda JPY 1.14T 40B 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Xencor USD 70.02M 59.31M 2024-12



Exelixis Obroty - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.